Detection and quantification of lupus anticoagulants in plasma from heparin treated patients, using addition of polybrene
Open Access
- 25 January 2006
- journal article
- research article
- Published by Springer Nature in Thrombosis Journal
- Vol. 4 (1) , 3
Abstract
Background: Lupus anticoagulants prolong clotting times in phospholipid-dependent coagulation tests. Lupus Ratio assays are integrated tests for lupus anticoagulants that may be based on APTT, RVVT or dPT clotting times. If a patient is being treated with unfractionated heparin, however, the heparin prolong clotting times and the diagnosis of lupus anticoagulant is invalidated. Commercial assays may have heparin neutralising agents added to their reagents. However, the type and efficacy of the heparin neutralisation is often not documented. We wanted to test the influence and efficacy of heparin neutralisers in the Lupus Ratio assay. Methods: Several heparin neutralisers were tested, and polybrene was chosen for further testing. Unfractionated heparin and/or polybrene were added to normal plasma and to plasma from patients with or without lupus anticoagulant and clotting times compared before and after the additions. Lupus anticoagulant-positive patients were given 5000 IU i.v. of unfractionated heparin and plasma was collected just before and five minutes after the injection. Lupus Ratios were calculated after polybrene was added to the postinjection samples. Results: The Lupus Ratio became slightly lower when polybrene was added to plasma without heparin. Plasma heparinised in vitro and plasma from patients that had received heparin, both had Lupus Ratios nearly identical to the Lupus Ratios calculated before any additions. Conclusion: By addition of polybrene to a final concentration of 7.9 μg/ml in test plasma, Lupus Ratio may be determined in lupus anticoagulant-negative as well as positive plasmas irrespective of the presence of heparin 0.0 – 1.3 U/ml.Keywords
This publication has 21 references indexed in Scilit:
- Dilute prothrombin time-based lupus ratio testThrombosis Research, 2002
- International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshopArthritis & Rheumatism, 1999
- Do Antiphospholipid Antibodies Interfere with Tissue Factor Pathway Inhibitor?Thrombosis Research, 1999
- A Comparison of Three Months of Anticoagulation with Extended Anticoagulation for a First Episode of Idiopathic Venous ThromboembolismNew England Journal of Medicine, 1999
- Anticardiolipin Antibodies Predict Early Recurrence of Thromboembolism and Death Among Patients with Venous Thromboembolism Following Anticoagulant TherapyThe American Journal of Medicine, 1998
- A quantitative, semi-automated and computer-assisted test for lupus anticoagulantThrombosis Research, 1993
- Guidelines on testing for the lupus anticoagulant. Lupus Anticoagulant Working Party on behalf of the BCSH Haemostasis and Thrombosis Task Force.Journal of Clinical Pathology, 1991
- In vitro neutralization of heparin in plasma prior to the activated partial thromboplastin time test: An assessment of four heparin antagonists and two anion exchange resinsThrombosis Research, 1986
- Polycations as possible substitutes for protamine in heparin neutralizationThrombosis Research, 1980
- A Comparison of two Heparin-Neutralizing Agents: Protamine and PolybreneScandinavian Journal of Clinical and Laboratory Investigation, 1960